# VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

Study · id `cardio:ct-nct06384599` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06384599](<https://clinicaltrials.gov/study/NCT06384599>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06384599

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 130 participants.

## Technical summary

Registry record NCT06384599. Allocation not applicable; no masking; primary purpose treatment. Start 2027-01-01 (anticipated); primary completion 2027-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT06384599, source copy `cardio:ctgov-nct06384599-2026-10-13`, retrieved 2026-10-26)
- Planned start: 2027-01-01 (anticipated) (ClinicalTrials.gov record NCT06384599, source copy `cardio:ctgov-nct06384599-2026-10-13`, retrieved 2026-10-26)
- Primary completion: 2027-05-01 (anticipated) (ClinicalTrials.gov record NCT06384599, source copy `cardio:ctgov-nct06384599-2026-10-13`, retrieved 2026-10-26)
- Completion: 2027-09-01 (anticipated) (ClinicalTrials.gov record NCT06384599, source copy `cardio:ctgov-nct06384599-2026-10-13`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT06384599, source copy `cardio:ctgov-nct06384599-2026-10-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06384599-2026-10-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: VT Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
- Condition: Ventricular Tachycardia
- Intervention (Device): VT Cryoablation System
- Lead sponsor: Adagio Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Adagio Medical (`cardio:org-adagio-medical`)

## Provenance

Content hash: b3203073d2e0225e917f7b9b273b2c60d10f51e12a4d088b47295dc1f517098b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
